Patents by Inventor Randall Mauldin

Randall Mauldin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240358800
    Abstract: The present disclosure provides pharmaceutical compositions of a chimeric protein comprising a factor VIII (FVIII) polypeptide and a von Wilobrand factor (VWF) polypeptide. Also disclosed are pharmaceutical kits and methods of using the disclosed pharmaceutical compositions to treat hemophilia A.
    Type: Application
    Filed: April 10, 2024
    Publication date: October 31, 2024
    Inventors: Tyler CARLAGE, Randall MAULDIN, Timothy MCCOY, Loubna Mzaalak TAZI
  • Publication number: 20240287158
    Abstract: The present disclosure provides pharmaceutical compositions of a chimeric protein comprising a factor VIII (FVIII) polypeptide and a von Willebrand factor (VWF) polypeptide. Also disclosed are pharmaceutical kits and methods of using the disclosed pharmaceutical compositions to treat hemophilia A.
    Type: Application
    Filed: June 23, 2022
    Publication date: August 29, 2024
    Inventors: Tyler CARLAGE, Randall MAULDIN, Loubna Mzaalak TAZI, Timothy R. MCCOY
  • Publication number: 20190064147
    Abstract: Provided herein, in some aspects, are methods of developing a biological therapeutic product. The methods can be used to formulate a biological therapeutic agent or screen biological therapeutic agents.
    Type: Application
    Filed: January 18, 2016
    Publication date: February 28, 2019
    Applicant: Biogen MA Inc.
    Inventors: Mark Krebs, Mariana Dimitrova, Kapil Gupta, Shantanu Sule, Randall Mauldin, Adnan Zunic, Lori Karpes